Artemether/lumefantrine and dihydroartemisinin/piperaquine to treat uncomplicated malaria in Ugandan children.
Phase of Trial: Phase III
Latest Information Update: 23 May 2014
Price : $35 *
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Dihydroartemisinin/piperaquine (Primary)
- Indications Falciparum malaria
- Focus Registrational; Therapeutic Use
- 23 May 2014 New trial record
- 13 May 2014 Results published in the Clinical Infectious Diseases.